The GNL is an anchor lab of the NIAID Biodefense Laboratory Network, which includes laboratories built by NIH at 14 universities throughout the U.S. with containment capabilities for biodefense research. The GNL is one of two labs with Biosafety Level 4 (BSL4) capabilities located on a U.S. university campus. The other is the National Emerging Infectious Disease Laboratory (NEIDL) located at Boston University. In addition, the GNL has extensive BSL3 capabilities where work on highly infectious pathogens, including SARS-CoV2, are studied and medical countermeasures such as antiviral and antibody therapies and vaccines are developed.
Through their independent research programs and collaborative efforts, these 14 laboratories work to improve understanding of dangerous pathogens that cause human disease and to develop diagnostics, vaccines and other medical countermeasures to defeat them. Network members also share best practices in Environmental Health and Safety, Biocontainment Engineering and Operations, Emergency Preparedness, and overall Lab Management.